UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Capital expenditures, 2025
- $521M
- YoY, 2025
- +111.2%
- 5-year CAGR
- +54.4%
- 10-year CAGR
- +26.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $521M | +111.2% |
| 2024 | $247M | +7.0% |
| 2023 | $230M | +66.0% |
| 2022 | $139M | +14.9% |
| 2021 | $121M | +103.7% |
| 2020 | $59M | −29.2% |
| 2019 | $84M | −54.6% |
| 2018 | $184M | +113.7% |
| 2017 | $86M | +127.1% |
| 2016 | $38M | −23.7% |
| 2015 | $50M | +5.1% |
| 2014 | $47M | +48.5% |
| 2013 | $32M | −71.5% |
| 2012 | $112M | +211.0% |
| 2011 | $36M | +93.0% |
| 2010 | $19M | −80.5% |
| 2009 | $95M | −23.3% |
| 2008 | $124M | — |